Amgen, Inc. v. Connecticut Retirement Plans & Trust Funds
Facts
Connecticut Retirement alleged that Amgen and several officers made misrepresentations and misleading omissions about the safety, efficacy, and marketing of two Amgen drugs, which allegedly inflated Amgen's stock price. Connecticut Retirement invoked the fraud-on-the-market presumption to seek certification of a class of investors who bought Amgen stock between the first alleged misrepresentation and the last alleged corrective disclosure. Amgen conceded that the market for its securities was efficient and did not contest the public character of the alleged statements. Amgen argued that class certification required proof that the alleged misrepresentations and omissions were material, and it offered rebuttal evidence aimed at showing immateriality.
Issue
Must a plaintiff seeking certification of a Rule 23(b)(3) securities-fraud class action under Section 10(b) and Rule 10b-5 prove the materiality of the alleged misrepresentations or omissions before class certification? Also, must the district court consider a defendant's rebuttal evidence directed solely to materiality at that stage?
Rule
Under Rule 23(b)(3), a securities-fraud plaintiff need not prove materiality at class certification to invoke the fraud-on-the-market presumption. Materiality is a common question because it is judged by an objective reasonable-investor standard, and failure of proof on materiality would end the case for all class members rather than create individual reliance issues. Merits inquiries at certification are permitted only to the extent necessary to determine whether Rule 23's prerequisites are satisfied.
See the holding & full analysis
Create a free KwikCourt account to unlock the rest of this brief — and practice the case.
- The court's holding and reasoning
- Doctrine tests, pitfalls & exam hypotheticals
- 10 practice questions + 4 AI-graded essays on this case
Test yourself
At class certification, Lakeshore Robotics argues the investors must first prove the statements were material before they may invoke the fraud-on-the-market presumption. How should the court rule?